These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

819 related items for PubMed ID: 1330300

  • 21. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A, Pfaff P, Lange W, Finke J.
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [Abstract] [Full Text] [Related]

  • 22. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 23. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 24. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E.
    J Immunol Methods; 2012 Nov 30; 385(1-2):60-70. PubMed ID: 22921685
    [Abstract] [Full Text] [Related]

  • 25. [Epstein-Barr virus associated lymphocyte proliferation].
    Stein H, Hummel M, Anagnostopoulos I, Korbjuhn P, Niedobitek G, Dallenbach F, Herbst H.
    Verh Dtsch Ges Pathol; 1992 Nov 30; 76():79-95. PubMed ID: 1283280
    [Abstract] [Full Text] [Related]

  • 26. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG.
    Eur J Immunol; 1990 Oct 30; 20(10):2293-9. PubMed ID: 2173662
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS.
    J Exp Med; 1993 Feb 01; 177(2):339-49. PubMed ID: 8381153
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.
    J Virol; 1988 Oct 01; 62(10):3747-55. PubMed ID: 2843672
    [Abstract] [Full Text] [Related]

  • 29. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 01; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 30. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May 01; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 31. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 32. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E.
    Proc Natl Acad Sci U S A; 1990 Apr 01; 87(8):2906-10. PubMed ID: 2158098
    [Abstract] [Full Text] [Related]

  • 33. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
    Rickinson AB, Moss DJ.
    Annu Rev Immunol; 1997 Apr 01; 15():405-31. PubMed ID: 9143694
    [Abstract] [Full Text] [Related]

  • 34. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R, Burrows SR, Nicholls J, Poulsen LM.
    Eur J Immunol; 1998 Feb 01; 28(2):451-8. PubMed ID: 9521052
    [Abstract] [Full Text] [Related]

  • 35. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
    Picchio GR, Kobayashi R, Kirven M, Baird SM, Kipps TJ, Mosier DE.
    Cancer Res; 1992 May 01; 52(9):2468-77. PubMed ID: 1314693
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ, Crawford DH, Thomas JA.
    J Gen Virol; 1993 Mar 01; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH, Wills A, Reece E, Fox Z.
    Can Med Assoc J; 1981 Oct 15; 125(8):845-9. PubMed ID: 6272957
    [Abstract] [Full Text] [Related]

  • 38. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G.
    J Gen Virol; 1989 Nov 15; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [Abstract] [Full Text] [Related]

  • 39. Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response.
    Moss DJ, Burrows SR, Suhrbier A, Khanna R.
    Ciba Found Symp; 1994 Nov 15; 187():4-13; discussion 13-20. PubMed ID: 7796675
    [Abstract] [Full Text] [Related]

  • 40. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G, Klein E, Kashuba E.
    Biochem Biophys Res Commun; 2010 May 21; 396(1):67-73. PubMed ID: 20494113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.